CFA
BIIB icon

CT Financial Advisors’s Biogen BIIB Stock Holding History

CT Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$251K Hold
917
– – 0.15% 133
2016
Q4 		$260K Hold
917
– – 0.16% 127
2016
Q3 		$287K Buy
917
+26
+3% +$7.7K 0.18% 115
2016
Q2 		$215K Buy
891
+290
+48% +$76.4K 0.13% 136
2016
Q1 		$156K Hold
601
– – 0.09% 171
2015
Q4 		$184K Hold
601
– – 0.11% 154
2015
Q3 		$175K Hold
601
– – 0.11% 149
2015
Q2 		$243K Hold
601
– – 0.14% 130
2015
Q1 		$254K Hold
601
– – 0.14% 129
2014
Q4 		$204K Buy
+601
New +$194K 0.15% 113
2014
Q1 		$254K Buy
+601
New +$191K 0.14% 129

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CT Financial Advisors's BIIB Position: Q1 2017 in Review

CT Financial Advisors held its Biogen (BIIB) position steady in Q1 2017 at 917 shares worth $251K. The position accounts for 0.15% of the portfolio, ranked #133.

CT Financial Advisors first reported a position in BIIB in Q1 2014 and has held it in 11 quarters since. The position peaked at $287K in Q3 2016. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • CT Financial Advisors held 917 shares of Biogen worth $251K as of Q1 2017.
  • CT Financial Advisors left its Biogen share count unchanged in Q1 2017.
  • Biogen made up 0.15% of CT Financial Advisors's portfolio in Q1 2017, its #133 holding.
  • CT Financial Advisors first reported a position in Biogen in Q1 2014 and has held it in 11 quarters since.
  • CT Financial Advisors's Biogen position peaked at $287K in Q3 2016.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.